IN8bio, Inc.
INAB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$30,437 | -$30,007 | -$28,521 | -$14,653 |
| Dep. & Amort. | $2,655 | $2,501 | $1,103 | $788 |
| Deferred Tax | $0 | $0 | -$4,163 | -$541 |
| Stock-Based Comp. | $5,000 | $0 | $3,467 | $2,195 |
| Change in WC | -$1,412 | -$204 | -$170 | -$1,839 |
| Other Non-Cash | $45 | $4,370 | $4,163 | $541 |
| Operating Cash Flow | -$24,149 | -$23,340 | -$24,121 | -$13,509 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$104 | -$600 | -$3,705 | -$309 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$83 | $0 | $0 | $0 |
| Investing Cash Flow | -$187 | -$600 | -$3,705 | -$309 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$794 | -$798 | -$615 | -$709 |
| Stock Issued | $9,943 | $27,842 | $9,542 | $36,327 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $5,035 | $0 | $61 | -$2,663 |
| Financing Cash Flow | $14,184 | $27,044 | $8,988 | $32,955 |
| Forex Effect | $0 | -$4 | $0 | $0 |
| Net Chg. in Cash | -$10,152 | $3,100 | -$18,838 | $19,137 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $21,538 | $18,182 | $37,272 | $18,135 |
| End Cash | $11,386 | $21,282 | $18,434 | $37,272 |
| Free Cash Flow | -$24,253 | -$23,940 | -$27,826 | -$13,818 |